Global Antiemetics Market, By Drug Class (5-HT3 Receptor Antagonists, Dopamine Antagonists, NK1 Receptor Antagonist, Antihistamines (H1 histamine receptor antagonists), Cannabinoids, Benzodiazepines, Anticholinergics, Steroids, Others), Application (Chemotherapy, Motion Sickness, Gastroenteritis, General Anesthetics, Opioid Analgesics, Dizziness, Pregnancy, Food Poisoning, Emotional Stress, Other), End-User (Hospitals, Clinics, Pharmacies, Online Pharmacies), Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights : Global Antiemetics Market
Antiemetics market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to reach at an estimated value of 5,525.28 billion and grow at a CAGR of 5.71% in the above-mentioned forecast period. Increasing number of cancer patients worldwide drives the antiemetics market.
Antiemetic is a type of drug which helps to prevent vomiting and nausea. They are commonly used to treat the side effects of opioid analgesics, general anesthetics, and chemotherapy. It can be used when the patient is suffering from illness such as dizziness, motion sickness, pregnancy and food poisoning. It may also be used in the case of gastroenteritis, especially if the patient is dehydrated. They also provide relief to the pregnant women, who undergo morning sickness, during the early phase of the pregnancy.
Increasing number of gastroenteritis patients is the vital factor escalating the market growth, also increased number of surgeries, rising healthcare expenditure due to rise in the disposable incomes, rising number of lifestyle diseases, rising health consciousness among people and rising number of hospitals all over the globe have enabled easy access to the people for surgeries which acts are the major factors among others driving the antiemetics market. Moreover, rising technological advancements and increasing modernization in the healthcare sector and rising research and development activities will further create new opportunities for antiemetics market in the forecasted period of 2021-2028.
However, lack of suitable animal model which will mimic the human responses to antiemetic therapy is the vital factor among others which will obstruct the market growth, and will further challenge the growth of antiemetics market in the forecast period mentioned above.
This antiemetics market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on antiemetics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Antiemetics Market Scope and Market Size
Antiemetics market is segmented on the basis of drug class, application, end-user and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of drug class, the antiemetics market is segmented into 5-HT3 receptor antagonists, dopamine antagonists, NK1 receptor antagonist, antihistamines (H1 histamine receptor antagonists), cannabinoids, benzodiazepines, anticholinergics, steroids and others.
- Based on application, the antiemetics market is segmented into chemotherapy, motion sickness, gastroenteritis, general anesthetics, opioid analgesics, dizziness, pregnancy, food poisoning, emotional stress and other.
- Based on end-user, the antiemetics market is segmented into hospitals, clinics, pharmacies and online pharmacies.
- The antiemetics market is also segmented on the basis of distribution channel into retail pharmacy, hospital pharmacy and online.
Global Antiemetics Market Country Level Analysis
Antiemetics market is analysed and market size insights and trends are provided by country, drug class, application, end-user and distribution channel as referenced above.
The countries covered in the antiemetics market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America and Europe dominates the antiemetics market due to rising rate of cancer affected population in this region. Asia-Pacific is the expected region in terms of growth in antiemetics market due to high incidence rate of gastroenteritis and other diseases with increasing number of cancer population in this region.
The country section of the antiemetics market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
Antiemetics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for antiemetics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the antiemetics market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Antiemetics Market Share Analysis
Antiemetics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to antiemetics market.
The major players covered in the antiemetics market report are GlaxoSmithKline plc., Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., Sanofi, Pfizer Inc., Mylan N.V., Eli Lilly and Company, Johnson & Johnson Services, Inc, Baxter., Dr. Reddy’s Laboratories Ltd., F. Hoffmann-La Roche Ltd, Ipca Laboratories Ltd, Eisai Co., Ltd, Abbott, Sanofi, Novartis AG, Kyowa Kirin Co., Ltd., Heron Therapeutics, Inc. and Aurobindo Pharma among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-